Palliative care is not hospice. It's about aligning treatment with the patient's values at any stage of illness. Every resident should be able to lead a goals-of-care conversation and manage common symptoms at end of life.
๐ค Goals of Care Conversation
When to Have the Conversation
Any new serious diagnosis (advanced cancer, end-stage organ failure, severe dementia)
Significant clinical deterioration or ICU admission
Repeated hospitalizations for chronic progressive disease
"Would you be surprised if this patient died in the next year?" -if no, initiate GOC discussion.
Framework -REMAP
Step
What to Say
R -Reframe
"I want to step back and talk about the big picture of what's going on."
E -Expect emotion
Pause. Acknowledge. "I can see this is hard to hear." NURSE: Name, Understand, Respect, Support, Explore.
M -Map values
"What matters most to you?" "What does a good day look like?" "Are there things worse than death to you?"
A -Align
"Based on what you've told me -that being independent and not suffering are most important -I'd recommend..."
P -Plan
Concrete next steps. Document. Communicate with team. Revisit as things change.
Code Status Discussion
Avoid: "Do you want us to do everything?" (misleading -implies no CPR = giving up)
Better: "If your heart were to stop, CPR involves chest compressions that often break ribs, a breathing tube, and electric shocks. In someone with your condition, the chance of surviving to leave the hospital is about ___%. Given what you've told me about what matters most to you, I would recommend..."
Make a recommendation. Patients want guidance, not just options.
๐ Symptom Management
Symptom
First-Line
Notes
Pain
Morphine (MS Contin) 2โ5 mg IV/SC q2โ4h PRN or oxycodone 5โ10 mg PO q4h. Scheduled + PRN for constant pain.
Titrate to comfort. No ceiling for opioids in end-of-life care. Add adjuncts: acetaminophen (scheduled), gabapentin (neuropathic), dexamethasone (bone mets, inflammation).
Dyspnea
Morphine (MS Contin) 2โ4 mg IV/SC q2โ4h PRN. Fan to face. Oxygen if hypoxic.
Opioids are the most effective treatment for dyspnea in palliative care. They reduce the sensation of breathlessness centrally. Low doses are safe and don't hasten death Opioids for Dyspnea Trial, 2003. Anxiolytics (lorazepam 0.5โ1 mg) if anxiety-driven.
Nausea / vomiting
Ondansetron (Zofran) 4โ8 mg IV q6h or haloperidol 0.5โ1 mg IV q6h (good for opioid-induced or chemical causes)
Match anti-emetic to mechanism: chemoreceptor trigger zone โ haloperidol/ondansetron. GI dysmotility โ metoclopramide. Raised ICP โ dexamethasone. Vestibular โ meclizine.
Anticholinergics reduce new secretion production. Suctioning is uncomfortable and often futile. Reposition to lateral. Reassure family -the sound is often more distressing to family than to the patient.
Rule out reversible causes first (urinary retention, constipation, pain, medication). If actively dying and refractory โ palliative sedation with midazolam or phenobarbital infusion (requires palliative care consult + family discussion).
๐ Overview
Overview
Palliative care improves quality of life through symptom management, GOC discussions, and psychosocial support. Appropriate at any illness stage -concurrent with curative treatment. Palliative care โ hospice.
๐งช Workup
Workup
ESAS symptom scores (0-10)
Functional status -PPS, ECOG
Prognostication -surprise question, PPI
Advance directives review
Psychosocial/spiritual screening
๐จ Management
Management
Pain: WHO ladder + adjuvants (gabapentin, duloxetine, dexamethasone)
Dyspnea: Morphine 2-5mg SL + fan at face + Oโ if hypoxic
An attending asks you to 'make the patient comfortable' -what specific orders do you write?
This is a practical question that catches many interns off guard. A complete comfort care order set includes: (1) Pain: morphine 2โ5 mg IV/SC q2h PRN (or current opioid equivalent). Scheduled if constant pain. (2) Dyspnea: morphine 2โ4 mg IV/SC q2h PRN (opioids are first-line for dyspnea). (3) Anxiety/agitation: lorazepam 0.5โ1 mg IV/SC q4h PRN. (4) Secretions (death rattle): glycopyrrolate 0.2 mg IV/SC q4h PRN or atropine 1% drops SL q4h.
How do you know when to give morphine for dyspnea vs when it will hasten death?
This is one of the most common misconceptions in medicine. Appropriately dosed opioids for dyspnea do NOT hasten death. This was definitively shown by Abernethy et al. (2003): low-dose morphine significantly improved dyspnea without affecting respiratory rate, oxygen saturation, or survival.
What is the REMAP framework for goals of care conversations?
R eframe -Set the stage: "I want to make sure we're on the same page about what's happening." Clarify medical reality without jargon. E xpect emotion -Pause. Let silence work. Acknowledge: "I can see this is really hard." Don't fill silence with medical facts.
How do you manage terminal dyspnea?
Dyspnea is the symptom patients and families fear most in the terminal phase. Management: (1) Morphine is first-line -2-5 mg PO/SL/SQ q2-4h PRN. Reduces central perception of breathlessness without clinically significant respiratory depression at appropriate doses Opioids for Dyspnea Trial, 2003. (2) Fan directed at face -stimulates V2 branch of trigeminal nerve โ reduces sensation of air hunger. Evidence-based and free
Clinical Examples
๐ Case 1, Transitioning to Comfort Measures
Patient: 78M with metastatic pancreatic cancer, ECOG 4, declining PO intake ร 2 weeks. Family ambivalent about hospice. Current: morphine PCA, ondansetron, IV fluids.
Key findings: PPS 20%. Recurrent SBO from peritoneal carcinomatosis. No further oncologic options. Patient previously expressed "no machines" but no formal advance directive.
Management:
Goals of care conversation using REMAP framework with patient and family
Transition PCA to SQ morphine infusion 2 mg/hr for comfort
D/C IV fluids (contributes to secretions and edema at end of life)
Add glycopyrrolate 0.2 mg SQ q4h PRN for secretions
Hospice referral, inpatient hospice given symptom burden
Teaching point: IV fluids at end of life often worsen symptoms (secretions, edema, dyspnea). Discontinuing is not "giving up", it is symptom management.
๐ Case 2, Refractory Cancer Pain
Patient: 62F with metastatic breast cancer to bone. Pain 9/10 despite oxycodone 40 mg q4h. Somnolent but still reporting severe pain. Cr 2.4 (new).
Key findings: Opioid neurotoxicity (myoclonus, somnolence with persistent pain). Renal failure accumulating active metabolites. Current opioid dose equivalent: 360 MME/day.
Management:
Opioid rotation to hydromorphone (no active renal metabolites), reduce by 25-50% for cross-tolerance
Dexamethasone 4 mg IV q6h for bone pain and peritumoral edema
Radiation oncology consult for palliative XRT to painful metastases
Add gabapentin 100 mg TID (renal dose) for neuropathic component
IV hydration to address prerenal AKI
Teaching point:Opioid rotation is indicated when dose escalation causes toxicity without adequate analgesia. Hydromorphone and fentanyl are preferred in renal failure.
๐ Case 3, Terminal Dyspnea Management
Patient: 85M with end-stage IPF, on 15L high-flow, SpOโ 78%. DNR/DNI. Progressive dyspnea with visible distress. Family at bedside.
Key findings: Terminal respiratory failure. No reversible cause. Patient previously documented desire for comfort-focused care. PPS 10%.
Management:
Morphine 2 mg IV q15min PRN for dyspnea (titrate to comfort, not respiratory rate)
Fan directed at face, stimulates trigeminal V2 branch, reduces air hunger
Lorazepam 0.5 mg SL q4h PRN for anxiety component
Continue supplemental Oโ for comfort (not to target SpOโ)
Proactive family communication: normalize Cheyne-Stokes breathing, explain death rattle
Teaching point: Morphine for dyspnea does not hasten death at appropriate doses. The principle of double effect permits symptom management even if it theoretically shortens life.
๐ฃ Sample Presentation
One-Liner
"Mr. Washington is a 82-year-old with advanced dementia (FAST 7c), recurrent aspiration pneumonia ร 3 admissions this year, and worsening functional status. Family requesting "everything" but primary team is concerned about escalating interventions."
Key Points to Cover on Rounds
Goals of care conversation needed. Current trajectory: advanced dementia with recurrent aspiration -antibiotics are treating the symptom, not the underlying cause. REMAP framework used: R (reframe: "his dementia is causing the pneumonias -antibiotics can't fix that"), E (expect emotion -family is grieving), M (map values: "what would he say if he could tell us?"), A (align), P (plan). Family shared that he previously said he "never wanted to be a burden." After discussion, family chose: comfort-focused care, treat symptoms (dyspnea with morphine 2 mg SL q2h PRN), no more antibiotics for aspiration, no intubation, no ICU. Hospice referral initiated. Palliative care following.
โก Summary
Summary
REMAP
Reframe โ Expect emotion โ Map values โ Align โ Plan. The gold standard framework for goals of care conversations.
Code Status โ GOC
Goals of care is about values and what matters. Code status is one small part. Don't lead with "do you want CPR?" -map values first.
Dyspnea
Morphine (first-line), fan at face, Oโ for hypoxic patients, benzodiazepines for anxiety component. Positioning. Discontinue SpOโ alarms in comfort care.
Pain
WHO ladder: non-opioid โ weak opioid โ strong opioid. Adjuvants for neuropathic: gabapentin, duloxetine. Dexamethasone for bone pain, bowel obstruction, cerebral edema.
Prognostication
PPS, ECOG, disease-specific models. Clinicians overestimate survival by 3-5ร. Use objective tools. Communicate uncertainty honestly.
When to Consult
Refractory symptoms, complex goals of care, family conflict, transition to hospice, existential/spiritual distress, withdrawal of life-sustaining treatment.
๐ One Pager
Palliative Care ยท One Pager
Palliative Care
REMAP framework for goals of care. Code status โ GOC. Morphine for dyspnea. Fan at face. Consult for refractory symptoms, complex GOC, family conflict.
๐งช REMAP Framework
Reframe (medical reality without jargon). Expect emotion (pause, acknowledge). Map values ("what matters most?"). Align (recommendation based on values). Plan (concrete next steps).
๐จ Symptom Management
Pain: WHO ladder (non-opioid โ weak โ strong opioid) + adjuvants (gabapentin, duloxetine). Dyspnea: morphine (first-line) + fan at face + Oโ if hypoxic. Nausea: ondansetron, haloperidol. Delirium: haloperidol, lorazepam.
๐ When to Consult
Refractory symptoms despite standard management. Complex goals of care conversations. Family conflict. Transition to hospice. Withdrawal of life-sustaining treatment. Existential/spiritual distress.